Pyxis Oncology (PYXS)
(Delayed Data from NSDQ)
$3.75 USD
+0.52 (16.10%)
Updated Oct 18, 2024 03:59 PM ET
After-Market: $3.80 +0.05 (1.33%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.32 |
EPS Last Quarter | -0.29 |
Last EPS Surprise | 12.12% |
ABR | 1.14 |
Earnings ESP
|
-10.06% |
---|---|
Current Year | -1.04 |
Next Year | -1.22 |
EPS (TTM) | -1.24 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 16.05M | NA |
# of Estimates | NA | NA | 3 | NA |
High Estimate | NA | NA | 16.15M | NA |
Low Estimate | NA | NA | 16.00M | NA |
Year ago Sales | 0.00M | 0.00M | NA | 16.05M |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.32 | -0.30 | -1.04 | -1.22 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -0.29 | -0.27 | -1.04 | -1.29 |
High Estimate | -0.30 | -0.25 | -0.89 | -0.98 |
Low Estimate | -0.35 | -0.37 | -1.29 | -1.35 |
Year ago EPS | -0.56 | -0.33 | -1.85 | -1.04 |
Year over Year Growth Est. | 42.86% | 9.09% | 43.78% | -16.73% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 1 | 1 | 0 | 1 |
Down Last 30 Days | 1 | 1 | 0 | 1 |
Down Last 60 Days | 1 | 1 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.32 | -0.30 | -1.04 | -1.22 |
7 Days Ago | -0.30 | -0.29 | -1.07 | -1.20 |
30 Days Ago | -0.30 | -0.29 | -1.07 | -1.20 |
60 Days Ago | -0.30 | -0.29 | -1.07 | -1.20 |
90 Days Ago | -0.28 | -0.29 | -1.09 | -1.30 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.37 | -1.07 | -1.33 |
Zacks Consensus Estimate | -0.32 | -0.30 | -1.04 | -1.22 |
Earnings ESP | -10.06% | -21.71% | -2.49% | -9.20% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.29 | -0.06 | -0.33 | -0.56 | NA |
Estimate | -0.33 | -0.27 | -0.49 | -0.57 | NA |
Difference | 0.04 | 0.21 | 0.16 | 0.01 | 0.11 |
Surprise | 12.12% | 77.78% | 32.65% | 1.75% | 31.08% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more